{"symbol": "VKTX", "companyName": "Viking Therapeutics Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.vikingtherapeutics.com", "description": "Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.", "CEO": "Brian Lian", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}